insuficiencia cardíaca fisiopatología · pdf filees potenciada en la...

121
Insuficiencia cardíaca FISIOPATOLOGÍA Rafael Porcile [email protected] D E P A R T A M E N T O D E C A R D I O L O G I A C A T E D R A D E F I S I O L O G Í A Universidad Abierta Interamericana [email protected]

Upload: hoangnhi

Post on 31-Jan-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Insuficiencia cardiacuteaca

FISIOPATOLOGIacuteA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 2: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 3: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 4: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 5: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 6: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

LEY DE

STARLING

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 7: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 8: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 9: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

rafaelporcilevaneduceduar

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 10: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

HIPOPERFUSION

ANTEROGRADA

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 11: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 12: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 13: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Insuficiencia cardiacuteaca

ACTIVACIOacuteN

ADRENERGICA Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 14: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 15: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

DOS MECANISMOS

bull Mecanismo neurogenico

reflejo

bull Mecanismo neuro endorino

rafaelporcilevaneduceduar

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 16: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Mecanismo

neuroigenico reflejo

BULBO Y PROTUBERANCIA

rafaelporcilevaneduceduar

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 17: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Mecanismo neurogenico

INHIBICION VAGAL

LIBERACION

SIMPATICA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 18: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 19: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

SISTEMA LIMBICO rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 20: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 21: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 22: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 23: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

BARORECEPTORES AORTICOS Y

CAROTIDEOS

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 24: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 25: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 26: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 27: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Sobrecarga adrenergics

bullMayor consumo de

oxigeno

bullReduccioacuten del potencial

de reposo status

arritmogenico

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 28: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Insuficiencia cardiacuteaca

ACTIVACIOacuteN S R A A Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 29: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

MECANISMOS

PSEUDOCOMPENSADORES

DE LA INSUFICIENCIA

CARDIacuteACA

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 30: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 31: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 32: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

NUEVOS ACTORES

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 33: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 34: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 35: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

La renina es una enzima

rafaelporcilevaneduceduar

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 36: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Casi toda la renina encontrada en

los SRA locales se deriva de la

renina renal

Los sistemas locales estaacuten regulados

independientemente del SRA sisteacutemico

pero pueden interactuar con eacutel Se han

identificado SRA locales en el corazoacuten

rintildeoacuten cerebro paacutencreas aparato

reproductor sistema linfaacutetico y el

tejido adiposo

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 37: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Bajo flujo

Hipotensioacuten

arterial

Hipertension

arterial

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 38: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 39: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 40: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Enzima conversora de angiotensina 2

La ECA 2 es una carboxypeptidasa que se une a

un residuo de Ang I para generar Ang 1-9 y a un

residuo de Ang II para formar Ang 1-7 La ECA

2 rintildeoacuten corazoacutehipotaacutelamo y pared aoacutertica

testiacuteculos La ECA 2 y la Ang 1-7 modula la

actividad aumentada del SRA claacutesico

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 41: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 42: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Se considera que la angiotensina 1-9 es

inactiva y su funcioacuten bioloacutegica auacuten no esta

claramente definida pero estudios en ratas

demuestran que potencia la

vasoconstriccioacuten mediada por la

angiotensina II Adicionalmente tanto

en humanos como en ratas el nivel de

angiotensina 1-9 en plasma es el doble que

el de angiotensina II y la primera se

acumula en organismos que han sido

tratados con inhibidores de ECA

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 43: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Angiotensina 1-9

Efecto protrombotico

reduciendo la fibrinoacutelisis

espontanea reduciendo la

concentracioacuten del activados

de plasminogeno en plasmina

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 44: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 45: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

SARA

LOCAL rafaelporcilevaneduceduar

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 46: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

El AGT y la renina provienen tanto de la

produccioacuten local como de la circulacioacuten La

ECA se expresa en cardiomiocitos y

fibroblastos al igual que el receptor de

prorrenina (RPR) que se une a eacutesta y facilita la

siacutentesis local de Ang II la cual tiene lugar tanto

en el espacio intersticial como a nivel

intracelular La siacutentesis extracelular de Ang II

depende generalmente de la prorrenina y la

ECA En cardiomiocitos la siacutentesis intracelular

de Ang II puede ocurrir en el citoplasma

mediada por renina y quimasa o en vesiacuteculas

secretoras rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 47: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 48: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 49: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

La angiotensina (Ang) (1-7) es un

peacuteptido bioactivo del SRA que

provoca vasodilatacioacuten diuresis y

natriuresis lo cual favorece la

disminucioacuten de la presioacuten arterial

particularmente en situaciones de

actividad aumentada de la Ang II

rafaelporcilevaneduceduar

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 50: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

angiotensina (1-7)

Su mecasismo es

PARACRINO

rafaelporcilevaneduceduar

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 51: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

La siacutentesis de la Ang 1-7 a partir de la

Ang I requiere de alguna de las

siguientes tres endopeptidasas tisulares

denominadas neprilisina prolil

endopeptidasa y timet oligopeptidasa

rafaelporcilevaneduceduar

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 52: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

La disminucioacuten de la liberacioacuten de NA provocada

por la Ang-(1-7) podriacutea ser la consecuencia de una

inhibicioacuten de la siacutentesis del neurotransmisor asiacute

como de un aumento en su recaptacioacuten neuronal

dos procesos que contribuiriacutean a reducir la

concentracioacuten de neurotransmisor en el espacio

sinaacuteptico Recientemente demostramos

que la Ang-(1-7) presenta un efecto inhibidor sobre

la siacutentesis de NA por estimulacioacuten de la degradacioacuten

de la tirosina hidroxilasa

enzima que cataliza la

etapa inical y limitante

en la biosiacutentesis de

catecolaminas

rafaelporcilevaneduceduar

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 53: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Relacioacuten ECAECA-2 Dependiendo del balance ECAECA-2

se obtendraacute los efectos de la Ang 1-7 o Ang II ya que si la relacioacuten ECAECA-2 es alta

se tendraacute mayores niveles de Ang II que de Ang 1-7 observaacutendose vasoconstriccioacuten

proliferacioacuten fibrosis

hipertrofia por su parte si la relacioacuten ECAECA-2 es baja se favorece la

formacioacuten de Ang 1-7 y predominaraacuten sus efectos

como la vasodilatacioacuten anti proliferacioacuten ECA Enzima Convertidora de Angiotensina ECA-2

Enzima Convertidora de Angiotensina - 2 (Tomado de Ferrario CM y col 1997 2006) [68] rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 54: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 55: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 56: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Angiotensina II

rafaelporcilevaneduceduar

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 57: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

FUENTES DE

ANGIOTENSINA

II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 58: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 59: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 60: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 61: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 62: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 63: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 64: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ALDOSTERONA

rafaelporcilevaneduceduar

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 65: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ALDOSTERONA

ANGIOTENSINA II

rafaelporcilevaneduceduar

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 66: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ALDOSTERONA

Retencion Na+

Retencion H2O

Excrecion K+

Excrecion Mg2+

Deposito de

colageno

Fibrosis - miocardica

- vascular

Edema

Arritmias

Competitive antagonist of the

aldosterone receptor

(myocardium arterial walls kidney)

ALDOSTERONA

rafaelporcilevaneduceduar

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 67: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Proliferacioacuten colaacutegeno

rafaelporcilevaneduceduar

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 68: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

APOPTOSIS

rafaelporcilevaneduceduar

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 69: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

FIBROSIS

+apoptosis

+hipertrofia

Remodelacioacuten rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 70: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 71: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 72: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 73: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 74: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

HORMAONA

ANTIDIURETICA

rafaelporcilevaneduceduar

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 75: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ADH

rafaelporcilevaneduceduar

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 76: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Reduccion de la natremia

ANGIOTENSINA II

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 77: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 78: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 79: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 80: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Angiotensina

III y

IV

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 81: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 82: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

En los gloacutebulos rojos existen

aminopeptidasas que inactivan a la Ang II

la que tiene una corta vida de

aproximadamente un minuto Estas

peptidasas convierten a la Ang II en

Angiotensina III (Ang III) que es un

heptapeacuteptido con el 50 de la actividad

presora de la primera y en el hexapeacuteptido

Angiotensina IV

rafaelporcilevaneduceduar

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 83: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Las acciones de la

angiotensina II y Ang III

soacutelo son mediadas por los

receptores AT1 y AT2

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 84: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 85: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ANGIOTENSIONA IV

bull RECEPTPRES ESPECIFICOS

ndash INSULIN REGULATED ANGIOTENSIN

PROTEIN IRAP ndash COMPARTEN CON LOS RECEPTORES DE

LA INSULINA A LA PROTEIONA

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4 rafaelporcilevaneduceduar

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 86: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ANGIOTENSIONA IV

bull INHIBE LA DEGRADACION DE

ANGIOTENSINA II

bull GENERANDO UNA DOWN REGULATION DE

LVV HEMORFINA 7 TAMBIEN

ENCONTRADA EN LOS RECEPTORES

INSULINICOS GLUT 4

bull Down regulation de GLUT 4

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 87: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 88: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

HIPOPERFUSION RENAL

HEPATICA

CEREGRAL

MECANISMOS PSEUDO

COMPENSADORES

PRESIONES gt 16 mm Hg

CONGESTION RETROGRADA

MECANISMOS

COMPRNSADORES

rafaelporcilevaneduceduar

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 89: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

MECANISMOS

COMPENSADORES

rafaelporcilevaneduceduar

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 90: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ADRENOMEDULINA rafaelporcilevaneduceduar

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 91: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ADRENOMEDULINA

bull ORIGINALMENTE AISLADA EN LAS CELULAS

DEL FEOCROMOCITOMA ES DE PRODUCCION MULTITISULAR

bull SECUENCIA AMINOACIDA SIMILAR A LA CALCITONINA

bull EFECTO POTENTE VASODILATADOR

bull ANTAGONISTA ALDOSTERONICO

bull EFECTO INOTROPICO POSITIVO POR VIA

DEL AMP CICLICO (VIA EXCLUSIVA)

bull SU CONCENTRACION PLASMATICA Y TISULAR ES POTENCIADA EN LA INSUFICIENCIA CARDIacuteACA EN PROPORCION DIRECTA A LA PRESION EN LA ARTERIA PULMONAR Y AL GRADO DE DISFUNCIOacuteN VENTRICULAR

bull MECANISMO COMPENSADOR EN ICC COacuteNICA

rafaelporcilevaneduceduar

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 92: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Plasma levels of adrenomedullin in

patients with mitral stenosis

Yamamoto et all Am Heart J 1998 Mar (3)542-9

bull Dosaje en sangre periferica

bull Notable incremento de

adrenomedulina directamente

proporcional a la presion en

arteria pulmonar

bull Significativa reduccioacuten de los dosajes

post valvuloplastia

rafaelporcilevaneduceduar

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 93: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Plasma adrenomedullin as an independent

predictor of future cardiovascular events in

high-risk patients comparison with C-

reactive protein and adiponectin Nishida H Horio T Suzuki Y Iwashima Y Kamide K Kangawa K Kawano Y

Division of Hypertension and Nephrology Department of Medicine National Cardiovascular

Center 5-7-1 Fujishirodai Suita Osaka 565-8565 Japan

bull These findings indicate that plasma

AM is a powerful independent

predictor of future CV events in

high-risk patients suggesting its

predictive value is superior to that of

hs-CRP or adiponectin

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 94: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Insuficiencia cardiacuteaca

PEPTIDOS ATRIALES

Y CEREBRALES

NATRIURETICOS Rafael Porcile

rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 95: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 96: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

ANP BNP

bull Brain Natriuretic Peptide

ndash 20 del ANP superando su concentracioacuten en IC

ndash Produccioacuten ventricular

bull Atrial Natriuretic Peptide

ndash Segregado por las celulas miocardicas en la

auricula en respuesta a la sobrecarga de volumen

ndash Polipeptido de entre 99 y 126 aa

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 97: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 98: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 99: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 100: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 101: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 102: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 103: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 104: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 105: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Neprilisina

bull La neprilisina degrada los peacuteptidos

natriureacuteticos bioloacutegicamente

activos incluyendo ANP BNP y

CNP pero no es capaz de degradar

al NT-proBNP

rafaelporcilevaneduceduar

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 106: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Neprilysin

zinc-dependent metalloprotease that cleaves peptides at

the amino side of hydrophobic residues and inactivates

several peptide hormones including glucagon

enkephalins substance P neurotensin oxytocin and

bradykinin[1] It also degrades the amyloid beta peptide

whose abnormal misfolding and aggregation in neural

tissue has been implicated as a cause of Alzheimers

disease Synthesized as a membrane-bound protein the

neprilysin ectodomain is released into the extracellular

domain after it has been transported from the Golgi

apparatus to the cell surface

rafaelporcilevaneduceduar

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 107: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Insuficiencia cardiacuteaca

FISIOPATOLOGIA DE

SENDROMES CARDIO

SISTEMICOS

Rafael Porcile rafaelporcilevaneduceduar

D E P A R T A M E N T O D E C A R D I O L O G I A

C A T E D R A D E F I S I O L O G Iacute A

Universidad Abierta Interamericana

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 108: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 109: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 110: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 111: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 112: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 113: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 1

Pathophysiological interactions between heart and kidney in type 1 cardiorenal syndrome (CRS) or ldquoacute CRSrdquo (abrupt worsening

of cardiac function eg acute cardiogenic shock or acute decompensation of chronic heart failure) leading to kidney injury ACE =

angiotensin-converting enzyme ANP = atrial natriuretic peptide BNP = B-type natriuretic peptide CO = cardiac output GFR =

glomerular filtration rate KIM = kidney injury molecule N-GAL = neutrophil gelatinase-associated lipocalin RAA = renin

angiotensin aldosterone Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 114: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 115: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 2

Pathophysiological interactions between heart and kidney in type 2 cardiorenal syndrome (CRS) or ldquochronic CRSrdquo (chronic

abnormalities in cardiac function eg chronic heart failure) causing progressive chronic kidney disease (CKD) Figure illustration

by Rob Flewell LVH = left ventricular hypertrophy RAA = renin angiotensin aldosterone

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 116: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 3

Pathophysiological interactions between heart and kidney in type 3 CRS or ldquoacute renocardiac syndromerdquo (abrupt worsening of

renal function eg acute kidney failure or glomerulonephritis) causing acute cardiac disorder (eg heart failure arrhythmia

pulmonary edema) MPO = myeloperoxidase other abbreviations as in Figure 1 Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 117: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 4

Pathophysiological interactions between heart and kidney in type 4 cardiorenal syndrome (CRS) or ldquochronic renocardiac syndromerdquo

(chronic kidney disease [CKD] eg chronic glomerular disease contributing to decreased cardiac function cardiac hypertrophy or

increased risk of adverse cardiovascular events) BMI = body mass index EPO = erythropoietin LDL = low-density lipoprotein

Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 118: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

Date of download

9192014

Copyright copy The American College of Cardiology

All rights reserved

From Cardiorenal Syndrome

J Am Coll Cardiol 200852(19)1527-1539 doi101016jjacc200807051

CRS Type 5

Pathophysiological interactions between heart and kidney in type 5 cardiorenal syndrome (CRS) or ldquosecondary CRSrdquo (systemic

condition eg diabetes mellitus sepsis causing both cardiac and renal dysfunction) LPS = lipopolysaccharide (endotoxin) RVR =

renal vascular resistance Figure illustration by Rob Flewell

Figure Legend

rafaelporcilevaneduceduar

rafaelporcilevaneduceduar

Page 119: Insuficiencia cardíaca FISIOPATOLOGÍA · PDF filees potenciada en la insuficiencia cardÍaca en proporcion directa a la presion en la arteria pulmonar y al grado de disfunciÓn ventricular

rafaelporcilevaneduceduar